Literature DB >> 23925861

Cortical metabolic deficits in a rat model of cholinergic basal forebrain degeneration.

Francesca Gelfo1, Laura Petrosini, Alessandro Graziano, Paola De Bartolo, Lorena Burello, Emilia Vitale, Arianna Polverino, Antonietta Iuliano, Giuseppe Sorrentino, Laura Mandolesi.   

Abstract

Evidence indicates that the degeneration of basal forebrain cholinergic neurons may represent an important factor underlying the progressive cognitive decline characterizing Alzheimer's disease (AD). However, the nature of the relationship between cholinergic depletion and AD is not fully elucidated. This study aimed at clarifying some aspects of the relation existing between deficits in cerebral energy metabolism and degeneration of cholinergic system in AD, by investigating the neuronal metabolic activity of several cortical areas after depletion of basal forebrain cholinergic neurons. In cholinergically depleted rats, we evaluated the neuronal metabolic activity by assaying cytochrome oxidase (CO) activity in frontal, parietal and posterior parietal cortices at four different time-points after unilateral injection of 192 IgG-saporin in the nucleus basalis magnocellularis. Unilateral depletion of cholinergic cells in the basal forebrain induced a bilateral decrease of metabolic activity in all the analyzed areas. Frontal and parietal cortices showed decreased metabolic activity even 3 days after the lesion, when the cholinergic degeneration was still incomplete. In posterior parietal cortex metabolic activity decreased only 7 days after the lesion. The possible molecular mechanisms underlying these findings were also investigated. Real-time PCR showed an increase of CO mRNA levels at 3, 7 and 15 days after the lesion both in frontal and parietal cortices, followed by normalization at 30 days. Western Blot analysis did not show any change in CO protein levels at any time-point after the lesion. Our findings support a link between metabolic deficit and cholinergic hypofunctionality characterizing AD pathology. The present model of cholinergic hypofunctionality provides a useful means to study the complex mechanisms linking two fundamental and interrelated phenomena characterizing AD from the early stages.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23925861     DOI: 10.1007/s11064-013-1120-2

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  54 in total

Review 1.  Cholinergic system during the progression of Alzheimer's disease: therapeutic implications.

Authors:  Elliott J Mufson; Scott E Counts; Sylvia E Perez; Stephen D Ginsberg
Journal:  Expert Rev Neurother       Date:  2008-11       Impact factor: 4.618

2.  Immunolesioning: selective destruction of neurons using immunotoxin to rat NGF receptor.

Authors:  R G Wiley; T N Oeltmann; D A Lappi
Journal:  Brain Res       Date:  1991-10-18       Impact factor: 3.252

Review 3.  Mitochondrial aging and dysfunction in Alzheimer's disease.

Authors:  Patrick G Sullivan; Maile R Brown
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2005-03       Impact factor: 5.067

Review 4.  Brain metabolism and brain disease: is metabolic deficiency the proximate cause of Alzheimer dementia?

Authors:  J P Blass
Journal:  J Neurosci Res       Date:  2001-12-01       Impact factor: 4.164

5.  Selective immunotoxic lesions of basal forebrain cholinergic cells: effects on learning and memory in rats.

Authors:  M G Baxter; D J Bucci; L K Gorman; R G Wiley; M Gallagher
Journal:  Behav Neurosci       Date:  1995-08       Impact factor: 1.912

Review 6.  Alzheimer's disease: a disorder of cortical cholinergic innervation.

Authors:  J T Coyle; D L Price; M R DeLong
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

Review 7.  Insights into the regulation of protein abundance from proteomic and transcriptomic analyses.

Authors:  Christine Vogel; Edward M Marcotte
Journal:  Nat Rev Genet       Date:  2012-03-13       Impact factor: 53.242

8.  Mitochondria, cognitive impairment, and Alzheimer's disease.

Authors:  M Mancuso; V Calsolaro; D Orsucci; C Carlesi; A Choub; S Piazza; G Siciliano
Journal:  Int J Alzheimers Dis       Date:  2009-07-06

9.  Cytochrome c oxidase is decreased in Alzheimer's disease platelets.

Authors:  Sandra Morais Cardoso; M Teresa Proença; Sancha Santos; Isabel Santana; Catarina R Oliveira
Journal:  Neurobiol Aging       Date:  2004-01       Impact factor: 4.673

10.  Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor.

Authors:  S Heckers; T Ohtake; R G Wiley; D A Lappi; C Geula; M M Mesulam
Journal:  J Neurosci       Date:  1994-03       Impact factor: 6.167

View more
  3 in total

1.  Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment.

Authors:  Michel J Grothe; Helmut Heinsen; Edson Amaro; Lea T Grinberg; Stefan J Teipel
Journal:  Cereb Cortex       Date:  2015-04-02       Impact factor: 5.357

Review 2.  The Regulatory Effects of Acetyl-CoA Distribution in the Healthy and Diseased Brain.

Authors:  Anna Ronowska; Andrzej Szutowicz; Hanna Bielarczyk; Sylwia Gul-Hinc; Joanna Klimaszewska-Łata; Aleksandra Dyś; Marlena Zyśk; Agnieszka Jankowska-Kulawy
Journal:  Front Cell Neurosci       Date:  2018-07-10       Impact factor: 5.505

3.  Effect of Placenta-Derived Mesenchymal Stem Cells in a Dementia Rat Model via Microglial Mediation: a Comparison between Stem Cell Transplant Methods.

Authors:  Jae Sung Cho; Jihyeon Lee; Da Un Jeong; Han Wool Kim; Won Seok Chang; Jisook Moon; Jin Woo Chang
Journal:  Yonsei Med J       Date:  2018-05       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.